[Desired and undesirable effects of cytostatic therapy].
D000728:Androgens / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002066:Busulfan / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D015122:Mercaptopurine / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D010936:Plant Extracts / Q000627:therapeutic use; D010944:Plants; D014228:Triaziquone / Q000627:therapeutic use; D014265:Triethylenemelamine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000728:Androgens; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D004967:Estrogens; D005938:Glucocorticoids; D010936:Plant Extracts; D002699:Chlorambucil; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D014228:Triaziquone; D014265:Triethylenemelamine; D002066:Busulfan
Erwünschte und unerwünschte Wirkungen der zytostatischen Therapie.